Proteomics in Small Cell Lung Cancer
ConditionSmall Cell Lung Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAalborg University Hospital
About this trial
The aim of this study is to gather insight into tumor-derived circulating extracellular vesicles-proteins in patients with newly diagnosed small cell lung cancer.
Eligibility criteria
Qualifiers
Written and signed informed consent
Histopathologically and/or cytologically newly-diagnosed SCLC
Measurable disease on CT scans
Eligibility to receive standard chemotherapy consisting of carboplatin and etoposide
Disqualifiers
Active biopsy-verified second malignancy other than non-melanoma skin cancer or cervical carcinoma in situ
Prior treatment for any malignant diseases other than non-melanoma skin cancer and cervical carcinoma in situ
Concomitant anticoagulation treatment (acetylsalicylic acid and clopidogrel are allowed)
Treatment with any other investigational agent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov